Literature DB >> 2701923

The pathophysiology of the pancreatic defect in cystic fibrosis.

P R Durie1.   

Abstract

Studies of the postnatal development of the pancrease in CF infants show a failure of acinar development and an increase in lumen volume with accumulation of secretory material within the pancreatic ducts. Our evaluation of functional changes within the exocrine pancreas are consistent with the pathologic findings. Impaired pancreatic fluid secretion appears to be a primary phenomenon of CF. We have shown that pancreatic secretions from CF patients also contain significantly higher concentrations of protein in comparison with pancreatic function-matched controls. Since total protein output is not increased, hyperconcentration of protein appears to be a direct result of a primary defect of fluid secretion. Protein hyperconcentration appears to predispose CF patients to protein precipitation and obstruction within small pancreatic ducts which, in turn, produces pancreatic acinar atrophy and fibrosis Our studies suggest that both bicarbonate and chloride transport within pancreatic ducts account for deficient fluid secretion in the pancreas of CF subjects.

Entities:  

Mesh:

Year:  1989        PMID: 2701923     DOI: 10.1111/apa.1989.78.s363.41

Source DB:  PubMed          Journal:  Acta Paediatr Scand Suppl        ISSN: 0300-8843


  14 in total

Review 1.  Molecular mechanism of pancreatic and salivary gland fluid and HCO3 secretion.

Authors:  Min Goo Lee; Ehud Ohana; Hyun Woo Park; Dongki Yang; Shmuel Muallem
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

Review 2.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

3.  IRBIT coordinates epithelial fluid and HCO3- secretion by stimulating the transporters pNBC1 and CFTR in the murine pancreatic duct.

Authors:  Dongki Yang; Nikolay Shcheynikov; Weizhong Zeng; Ehud Ohana; Insuk So; Hideaki Ando; Akihiro Mizutani; Katsuhiko Mikoshiba; Shmuel Muallem
Journal:  J Clin Invest       Date:  2008-12-01       Impact factor: 14.808

Review 4.  Molecular pathways for intracellular cholesterol accumulation: common pathogenic mechanisms in Niemann-Pick disease Type C and cystic fibrosis.

Authors:  Nicholas L Cianciola; Cathleen R Carlin; Thomas J Kelley
Journal:  Arch Biochem Biophys       Date:  2011-09-05       Impact factor: 4.013

5.  IRBIT governs epithelial secretion in mice by antagonizing the WNK/SPAK kinase pathway.

Authors:  Dongki Yang; Qin Li; Insuk So; Chou-Long Huang; Hideaki Ando; Akihiro Mizutani; George Seki; Katsuhiko Mikoshiba; Philip J Thomas; Shmuel Muallem
Journal:  J Clin Invest       Date:  2011-02-07       Impact factor: 14.808

6.  Polarized distribution of HCO3- transport in human normal and cystic fibrosis nasal epithelia.

Authors:  Anthony M Paradiso; Raymond D Coakley; Richard C Boucher
Journal:  J Physiol       Date:  2003-01-31       Impact factor: 5.182

Review 7.  Potassium channels in pancreatic duct epithelial cells: their role, function and pathophysiological relevance.

Authors:  Viktória Venglovecz; Zoltán Rakonczay; Michael A Gray; Péter Hegyi
Journal:  Pflugers Arch       Date:  2014-07-31       Impact factor: 3.657

8.  Ethanol and its non-oxidative metabolites profoundly inhibit CFTR function in pancreatic epithelial cells which is prevented by ATP supplementation.

Authors:  L Judák; P Hegyi; Z Rakonczay; J Maléth; M A Gray; V Venglovecz
Journal:  Pflugers Arch       Date:  2013-08-16       Impact factor: 3.657

9.  Determinants of coupled transport and uncoupled current by the electrogenic SLC26 transporters.

Authors:  Ehud Ohana; Nikolay Shcheynikov; Dongki Yang; Insuk So; Shmuel Muallem
Journal:  J Gen Physiol       Date:  2011-02       Impact factor: 4.086

10.  Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency.

Authors:  N Peretti; V Marcil; E Drouin; E Levy
Journal:  Nutr Metab (Lond)       Date:  2005-05-03       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.